Pharmaview

 

 

Click here to view a brief demonstration of Pharmaview.

 

Victrelis and Incivek Launch: The Revolution of the HCV Market Has Begun

 

 

 

In this article, the Pharmaview team discusses the evolution of the hepatitis C virus market with the launch of Victrelis and Incivek.

Click here to download paper.

 

 

Invaluable Corporate and Commercial Analysis of the Biopharmaceutical Industry

• Link to client portal
• Download brochure

Pharmaview offers all the insight you need to understand how each player in the biopharmaceutical industry functions.

Financial analysis, company strategies, drug and therapeutic profiles and examination of major market events—all are included in a subscription to Pharmaview. With its wealth of industry experience and independent objective insight, Decision Resources’ Pharmaview offers you the information you need to make the right decisions for your business.

Features

Regular Updating—Analysis is updated and reviewed regularly. Decision Resources’ analysts cover a range of therapy area conferences, company R&D days, annual general meetings and quarterly earnings conference calls, providing analysis and insight updated directly onto the Pharmaview platform.

Competitive Assessment Calls—The Pharmaview team conducts regular analyst calls on the current issues and drivers within the industry, including opinion and insight on key company deals, evolving therapeutic dynamics and the macroenviromental changes taking place within the drug industry.

Market Analyzer—A quantitative tool that allows users to track market sizes, assess barriers to market entry, quickly benchmark internal forecasts and analyze the potential of a licensing candidate. Data is updated three times a year based on company-reported sales.

Easy-to-navigate Interface—Search functionality allows users to quickly find relevant information across the entire research suite while hyperlinks allow users to quickly view relevant company, therapeutic area or industry content.